Others have shown that human patients with high CRC IL-25 expression have worse 5-year overall survival than stage IV CRC patients with low IL-25 expression (80), indicating that IL-25 may contribute to CRC disease pathogenesis. Here, IL25 is linked to colorectal carcinoma.